Status: current, Defined. Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4674247012 | Spironolactone 50 mg and torasemide 20 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
4674248019 | Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
4674249010 | Spironolactone 50 mg and torsemide 20 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Spironolactone 50 mg and torasemide 20 mg oral tablet | Is a | Spironolactone and torasemide only product in oral dose form | true | Inferred relationship | Some | ||
Spironolactone 50 mg and torasemide 20 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Spironolactone 50 mg and torasemide 20 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Spironolactone 50 mg and torasemide 20 mg oral tablet | Plays role | Loop diuretic therapeutic role | true | Inferred relationship | Some | ||
Spironolactone 50 mg and torasemide 20 mg oral tablet | Plays role | Potassium-sparing diuretic therapeutic role | true | Inferred relationship | Some | ||
Spironolactone 50 mg and torasemide 20 mg oral tablet | Has precise active ingredient | Torsemide | true | Inferred relationship | Some | 1 | |
Spironolactone 50 mg and torasemide 20 mg oral tablet | Has BoSS | Torsemide | true | Inferred relationship | Some | 1 | |
Spironolactone 50 mg and torasemide 20 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Spironolactone 50 mg and torasemide 20 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Spironolactone 50 mg and torasemide 20 mg oral tablet | Has precise active ingredient | Spironolactone | true | Inferred relationship | Some | 2 | |
Spironolactone 50 mg and torasemide 20 mg oral tablet | Has BoSS | Spironolactone | true | Inferred relationship | Some | 2 | |
Spironolactone 50 mg and torasemide 20 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Spironolactone 50 mg and torasemide 20 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets